Why the Quality of Listening Equipment Matters for Women’s Cardiovascular Safety

This piece is for general information and discussion only. It is not medical or legal advice.

Early thinking for this analysis was informed in part by themes raised in Episode 72 of the GPnotebook Podcast, which discussed variation in cardiovascular assessment tools.

Context and why this issue matters

Cardiovascular disease remains one of the leading causes of death for women in the UK. Much attention focuses on improving symptom recognition, reducing diagnostic bias and expanding access to investigations. Less visible is a quieter systems factor: variation in the basic tools used to listen to the heart and lungs.

Stethoscopes and related auscultatory equipment shape the reliability of bedside cardiovascular assessment. Their acoustic quality affects whether clinicians can detect quiet murmurs, gallops, friction rubs, irregular rhythms or faint respiratory changes. When equipment quality varies between services, the capacity to recognise early abnormalities may vary too.

For women, whose symptoms may present atypically and are sometimes attributed to anxiety or pregnancy‑related change, lower‑quality listening equipment can contribute to diagnostic blind spots.

Evidence and policy

Public procurement information shows that the NHS uses a national framework for patient assessment devices, including stethoscopes. Suppliers must meet policy and sustainability requirements set by NHS England. The framework, however, does not specify a uniform acoustic performance standard.

Investigations into NHS procurement describe tensions between cost control and equipment quality. Parliamentary scrutiny has highlighted the importance of clinician involvement in purchasing decisions. High‑cost medical devices have more structured oversight, but routine tools such as stethoscopes are purchased locally under constrained budgets.

Some regions have piloted enhanced and digital stethoscopes. An evaluation in the North East and North Cumbria reported perceived benefits in acoustic clarity, remote consultation and training. These pilots remain limited in scale.

How equipment variation plays out for women

Guidance-based expectations

National cardiovascular and primary care guidance highlights that clinicians typically assess cardiac and respiratory function through structured histories and examinations. This includes listening for murmurs, added sounds, irregular rhythms, fluid‑related breath sounds and focal respiratory changes.

During pregnancy and after birth, national recommendations emphasise recognising new or worsening breathlessness, tachycardia, chest discomfort, palpitations or new murmurs that may indicate conditions such as peripartum cardiomyopathy, valvular disease, acute coronary syndrome or pulmonary embolism.

These expectations rely on equipment capable of detecting quiet abnormalities.

What national reviews say women often report

Maternal mortality enquiries and patient safety reviews repeatedly describe women reporting chest tightness, palpitations, severe fatigue or disproportionate breathlessness and struggling to have these concerns fully explored. Subtle signs were sometimes interpreted as reassuring despite risk factors.

Where equipment quality varies, and where women’s reports are already more likely to be minimised, early signs of deterioration may be easier to miss.

Pregnancy, birth and the year after birth

Pregnancy places physiological strain on the cardiovascular system. Cardiac disease remains a leading cause of maternal mortality in the UK. Clinicians frequently assess symptoms that may be physiological or early signs of cardiovascular compromise.

Maternal mortality enquiries describe many cases where deterioration became evident in the postnatal period. Women may present to community midwifery, primary care, urgent treatment centres or emergency departments. Equipment varies across these settings. Basic analogue stethoscopes purchased within tight budgets may have different levels of acoustic clarity.

The combination of atypical symptoms, multiple care transitions and variation in equipment can create blind spots.

System watchpoints

This section highlights system patterns seen in research, guidance and investigations. It is not medical or legal advice, and it is not a checklist for your own care.

Who the evidence represents

Procurement data describe frameworks rather than frontline variation. Research into auscultation quality often comes from specialist settings rather than maternity, primary care or urgent care. Evidence on equipment variation across women’s pathways remains limited.

Digital design

Digital stethoscopes may offer amplification, noise reduction and recording features. Their value depends on training, maintenance and integration into pathways. Pilot studies remain small and geographically narrow.

Transitions of care

Women may be assessed across maternity, primary care, community services, ambulance services and emergency care. Each setting may use different models, ages and maintenance cycles of equipment.

Equity

Investigations frequently describe women’s symptoms being attributed to non‑cardiac causes. Where equipment has variable clarity, subtle signs may be harder to detect, widening inequities.

Procurement pathways

Routine tools are often purchased locally under constrained budgets. Reviews highlight the importance of clinician involvement in procurement decisions.

What is improving

NHS procurement reforms are moving towards more standardised systems. National oversight of high‑cost devices provides potential models for improving assurance for routine equipment.

The patient assessment devices framework includes policy and sustainability requirements for suppliers. Local pilots of enhanced and digital stethoscopes show interest in strengthening bedside cardiovascular assessment.

Where further improvement might come from

System‑level opportunities include evaluating whether minimum acoustic standards for stethoscopes would improve consistency, strengthening clinical involvement in procurement, expanding evaluation of digital stethoscopes across maternity and primary care, improving transparency around replacement cycles and integrating equipment quality into safety improvement work.

Readers are invited to share evidence or system-level insights by email. Please do not send personal or identifiable information.

Reflective questions for off-blog discussion

For clinicians

  1. How consistent is the quality of listening equipment across the settings where you work?
  2. Has equipment quality influenced your confidence when assessing subtle cardiovascular signs?
  3. How are stethoscopes and related tools chosen and replaced in your service?
  4. Are enhanced or digital devices available, and how are they used?
  5. What safeguards help ensure that subtle cardiovascular findings in women are not missed?

For patients

  1. How easy has it been to feel listened to when reporting heart or breathing symptoms?
  2. Have you noticed differences in how clinicians examine your heart and lungs across services?
  3. Do explanations about cardiovascular symptoms feel consistent across settings?
  4. How confident have you felt in the thoroughness of cardiovascular checks you have received?
  5. What system changes would help assessments feel more reliable?

Mandatory disclaimer

This article is for general information and discussion only. It is not medical or legal advice, nor a substitute for professional advice. To contribute evidence, ideas, or corrections, please email womenshealthproject@outlook.com. Please do not share personal data when emailing. Individual cases cannot be reviewed. This project does not offer any form of legal service and cannot assist with complaints, claims or individual advocacy.

This platform is independent and not affiliated with any law firm, regulator, inquiry or clinical body.

© 2026 Women’s Health Inquiry Project (WHIP). This article includes original analysis of material from publicly available national sources. It may not be reproduced without permission.

References

  1. Health Innovation North East and North Cumbria. EKO Digital Stethoscope Evaluation Report. 2024. Available at: https://healthinnovationnenc.org.uk/wp-content/uploads/2024/05/EKO-evaluation-report-May-2024.pdf. Accessed: 08 Mar 2026.
  2. NHS Supply Chain. Patient Assessment Devices: Contract Launch Brief. Available at: https://www.supplychain.nhs.uk/product-information/contract-launch-brief/patient-assessment-devices/. Accessed: 08 Mar 2026.
  3. NHS England. National Supply System for High‑Cost Tariff‑Excluded Devices. Available at: https://www.england.nhs.uk/commissioning/spec-services/key-docs/medical-devices/. Accessed: 08 Mar 2026.
  4. UK Parliament Public Accounts Committee. NHS Supply Chain and Efficiencies in Procurement. Available at: https://publications.parliament.uk/pa/cm5804/cmselect/cmpubacc/453/report.html. Accessed: 08 Mar 2026.
  5. GPnotebook Podcast. Episode 72. Dated 21 April 2023. Accessed via Spotify: 08 Mar 2026.